Our Portfolio

More than ever, technology and life science companies are expected to achieve superior performance levels at a faster rate, with less equity capital and against well capitalized competitors that may have “first to market advantage."

As a result, entrepreneurs must develop a financing strategy that blends equity and debt capital, thereby minimizing dilution, lowering cost of capital and providing strategic advantage to achieve success.

Hercules Technology Growth Capital focuses exclusively on technology and life science related companies, including biotechnology, medical devices, software, electronics and computer hardware, communications and networking as well as semiconductors and components.

We offer a full array of financing solutions designed to serve each company’s specific capital needs, ranging from senior secured subordinated venture debt loans to equipment specific venture leasing loans. Our loans range from $1 million to $30 million, and we also have the capability to underwrite transactions up to $40 million.  We structure our financing solutions to foster long-term growth, ensure financial stability and maximize shareholder value.